Last reviewed · How we verify
Muscle Relaxant
Muscle Relaxant is a Muscle relaxant Small molecule drug developed by Korea University Anam Hospital. It is currently FDA-approved for Muscle spasticity and spasms, Musculoskeletal pain and stiffness. Also known as: Muscle relaxant (rocuronium).
Muscle relaxants reduce muscle tension and spasticity by depressing neuromuscular transmission or central nervous system activity.
Muscle relaxants reduce muscle tension and spasticity by depressing neuromuscular transmission or central nervous system activity. Used for Muscle spasticity and spasms, Musculoskeletal pain and stiffness.
At a glance
| Generic name | Muscle Relaxant |
|---|---|
| Also known as | Muscle relaxant (rocuronium) |
| Sponsor | Korea University Anam Hospital |
| Drug class | Muscle relaxant |
| Modality | Small molecule |
| Therapeutic area | Neurology / Musculoskeletal |
| Phase | FDA-approved |
Mechanism of action
Muscle relaxants work through various mechanisms depending on the specific agent—some act centrally to reduce motor neuron excitability, while others may act peripherally at the neuromuscular junction. They are used to alleviate muscle stiffness, spasms, and pain associated with musculoskeletal conditions.
Approved indications
- Muscle spasticity and spasms
- Musculoskeletal pain and stiffness
Common side effects
- Drowsiness
- Dizziness
- Fatigue
- Headache
Key clinical trials
- Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation (NA)
- Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia (NA)
- A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias. (PHASE2, PHASE3)
- Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
- The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer (PHASE2)
- Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures (NA)
- Evaluation of Percutaneous Cryoneurotomy Compared to Surgical Open Neurotomy for the Management of Equinovarus Foot Deformity in Patients With Refractory Lower Limb Spasticity After Stroke (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Muscle Relaxant CI brief — competitive landscape report
- Muscle Relaxant updates RSS · CI watch RSS
- Korea University Anam Hospital portfolio CI
Frequently asked questions about Muscle Relaxant
What is Muscle Relaxant?
How does Muscle Relaxant work?
What is Muscle Relaxant used for?
Who makes Muscle Relaxant?
Is Muscle Relaxant also known as anything else?
What drug class is Muscle Relaxant in?
What development phase is Muscle Relaxant in?
What are the side effects of Muscle Relaxant?
Related
- Drug class: All Muscle relaxant drugs
- Manufacturer: Korea University Anam Hospital — full pipeline
- Therapeutic area: All drugs in Neurology / Musculoskeletal
- Indication: Drugs for Muscle spasticity and spasms
- Indication: Drugs for Musculoskeletal pain and stiffness
- Also known as: Muscle relaxant (rocuronium)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing